1991 Volume 39 Issue Supplement4 Pages 884-886
We evaluated the clinical effect of sparfloxacin (SPFX), on 10 cases of external eye disease including conjunctivitis (5 cases), dacryocystitis (2), blepharoconjunctivitie (2) and canaliculitis (1). The drug was administered orally in doses of 200-300mg divided into two or three times a day for 7-8 days. The clinical response was excellent in 2 patients, good in 5, and fair in 3 No side effects were found in any of the patients.